NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
19.07
-0.11 (-0.55%)
Jun 21, 2024, 4:00 PM EDT - Market closed

NovoCure Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2013
Cash & Equivalents
242.56115.83209.61246.17179.42
Upgrade
Short-Term Investments
669.8854.1728.9607.9148.77
Upgrade
Cash & Cash Equivalents
912.36969.93938.51854.08328.19
Upgrade
Cash Growth
-5.94%3.35%9.89%160.24%32.33%
Upgrade
Receivables
83.9112.22110.59117.9488.06
Upgrade
Inventory
38.1529.3824.4327.4223.7
Upgrade
Total Current Assets
1,0341,1121,074999.44439.95
Upgrade
Property, Plant & Equipment
97.768.9653.8841.6334.6
Upgrade
Other Long-Term Assets
14.0211.1612.0910.914.9
Upgrade
Total Long-Term Assets
111.7280.1265.9752.5439.5
Upgrade
Total Assets
1,1461,1921,1391,052479.45
Upgrade
Accounts Payable
94.3985.272.653.6586.31
Upgrade
Deferred Revenue
02.886.4812.147.81
Upgrade
Other Current Liabilities
84.7270.763.5347.83-7.81
Upgrade
Total Current Liabilities
179.12158.78142.6113.6186.31
Upgrade
Long-Term Debt
596.24584.27575.21444.2163.56
Upgrade
Other Long-Term Liabilities
8.287.4311.1917.6511.78
Upgrade
Total Long-Term Liabilities
604.52591.7586.4461.85175.35
Upgrade
Total Liabilities
783.63750.48729575.46261.66
Upgrade
Total Debt
596.24584.27575.21444.2163.56
Upgrade
Debt Growth
2.05%1.57%29.49%171.57%9.58%
Upgrade
Retained Earnings
-985.5-778.46-685.93-631.08-650.89
Upgrade
Comprehensive Income
-5.47-2.43-3.17-3.83-2.77
Upgrade
Shareholders' Equity
362.5441.17410.49476.53217.79
Upgrade
Net Cash / Debt
316.12385.66363.29409.88164.62
Upgrade
Net Cash / Debt Growth
-18.03%6.16%-11.37%148.98%66.71%
Upgrade
Net Cash Per Share
2.973.683.513.761.69
Upgrade
Working Capital
855.29952.75930.92885.83353.64
Upgrade
Book Value Per Share
3.414.213.974.722.24
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).